Comparative risk of rheumatoid arthritis between glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in type 2 diabetes.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Comparative risk of rheumatoid arthritis between glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in type 2 diabetes.
- Published In:
- Journal of autoimmunity, 157, 103493 (2025)
- Authors:
- Yen, Fu-Shun, Wang, Shiow-Ing, Hwu, Chii-Min, Huang, Chien-Wei, Chang, Renin, Hsu, Chih-Cheng, Wei, James Cheng-Chung
- Database ID:
- RPEP-14372
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-14372APA
Yen, Fu-Shun; Wang, Shiow-Ing; Hwu, Chii-Min; Huang, Chien-Wei; Chang, Renin; Hsu, Chih-Cheng; Wei, James Cheng-Chung. (2025). Comparative risk of rheumatoid arthritis between glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in type 2 diabetes.. Journal of autoimmunity, 157, 103493. https://doi.org/10.1016/j.jaut.2025.103493
MLA
Yen, Fu-Shun, et al. "Comparative risk of rheumatoid arthritis between glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in type 2 diabetes.." Journal of autoimmunity, 2025. https://doi.org/10.1016/j.jaut.2025.103493
RethinkPeptides
RethinkPeptides Research Database. "Comparative risk of rheumatoid arthritis between glucagon-li..." RPEP-14372. Retrieved from https://rethinkpeptides.com/research/yen-2025-comparative-risk-of-rheumatoid
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.